Our Partners > Diamond Sponsors 2016


Founded in 1995, Acorda develops therapies that restore neurological function to people living with nervous system disorders. Acorda has an industry leading pipeline of novel neurological therapies addressing a range of disorders, including multiple sclerosis, Parkinson’s disease, post-stroke walking deficits, epilepsy and migraine. Acorda markets three FDA-approved therapies, including AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg. Please visit www.acorda.com, our Facebook and LinkedIn pages, and follow @acordanews on Twitter to learn more.

Lundbeck is proud to support the Parkinson’s Unity Walk, and we look forward to walking alongside the Parkinson’s disease community in April! As a global pharmaceutical company with a mission to help people living with psychiatric and neurological disorders, we push the boundaries of science by targeting the underlying mechanisms of brain disorders and aiming for solutions that can alter the course of a disease. To drive this mission in the U.S., nearly 800 employees are engaged in the research, development, production, marketing and sale of innovative specialty therapies that fulfill unmet medical needs. Lundbeck is actively involved with hundreds of local and national U.S. events each year that support our disease communities. Your stories inspire us to innovate, discover and produce. To learn more, visit us at www.LundbeckUS.com and connect with us on Twitter at @LundbeckUS.


At UCB, everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” We have a passionate, long-term commitment to discovering and developing innovative medicines that transform the lives of people living with severe diseases of the immune system and the central nervous system. We do that by connecting with patients and their families around the world living with the physical and social burdens of severe disease. Those connections offer new perspectives, drive innovation, and offer the hope of a new generation of therapies that are helping to transform lives.

With a team of more than 8,500 employees and operations in 40 countries, we are a global biopharmaceutical company investing nearly 25% of revenue in cutting-edge scientific research to meet unmet patient needs. The company is based in Brussels, Belgium, with U.S. headquarters located in Atlanta, Georgia.


US WorldMeds is proud to be a Diamond Sponsor at this year’s Parkinson’s Unity Walk. US WorldMeds is committed to supporting patients and care partners to increase Parkinson’s disease awareness and help improve the quality of care. Stop by our tent to learn about our treatment options, our Circle of Care™ Nurse Network and our Parkinson’s support initiatives.



Click for a printer friendly version